2018-2023 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Report

August 2018 | 138 pages | ID: 29D97DABD29EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global ICAD (Intracranial Atherosclerotic Disease) Pathology market for 2018-2023.
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.
ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.
North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.
Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Over the next five years, LPI(LP Information) projects that ICAD (Intracranial Atherosclerotic Disease) Pathology will register a 8.7% CAGR in terms of revenue, reach US$ 220 million by 2023, from US$ 130 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• primarily split into
• Stent
• PTA Balloon

Segmentation by application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Stryker
• Balt
• TERUMO
• MicroPort
• Acandis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global ICAD (Intracranial Atherosclerotic Disease) Pathology consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of ICAD (Intracranial Atherosclerotic Disease) Pathology market by identifying its various subsegments.
• Focuses on the key global ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the ICAD (Intracranial Atherosclerotic Disease) Pathology with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of ICAD (Intracranial Atherosclerotic Disease) Pathology submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2013-2023
  2.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption CAGR by Region
2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
  2.2.1 primarily split into
  2.2.2 Stent
  2.2.3 PTA Balloon
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
  2.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
  2.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2013-2018)
  2.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Type (2013-2018)
2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
  2.5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
  2.5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value and Market Share by Application (2013-2018)
  2.5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Application (2013-2018)

3 GLOBAL ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY BY PLAYERS

3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players
  3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Players (2016-2018)
  3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players (2016-2018)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players
  3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players (2016-2018)
  3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players (2016-2018)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Players
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY BY REGIONS

4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology by Regions
  4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Regions
  4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Regions
4.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth
4.3 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth
4.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth
4.5 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth

5 AMERICAS

5.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries
  5.1.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018)
  5.1.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018)
5.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
5.3 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries
  6.1.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018)
  6.1.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018)
6.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
6.3 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
  7.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018)
  7.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018)
7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries
  8.1.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018)
8.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type
8.3 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
10.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customer

11 GLOBAL ICAD (INTRACRANIAL ATHEROSCLEROTIC DISEASE) PATHOLOGY MARKET FORECAST

11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast (2018-2023)
11.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Regions
  11.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Regions (2018-2023)
  11.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Type
11.8 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Stryker
  12.1.1 Company Details
  12.1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
  12.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Stryker News
12.2 Balt
  12.2.1 Company Details
  12.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
  12.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Balt News
12.3 TERUMO
  12.3.1 Company Details
  12.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
  12.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 TERUMO News
12.4 MicroPort
  12.4.1 Company Details
  12.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
  12.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 MicroPort News
12.5 Acandis
  12.5.1 Company Details
  12.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
  12.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Acandis News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of ICAD (Intracranial Atherosclerotic Disease) Pathology
Table Product Specifications of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
Figure Market Research Methodology
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth Rate 2013-2023 (K Units)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth Rate 2013-2023 ($ Millions)
Table ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of primarily split into
Table Major Players of primarily split into
Figure Product Picture of Stent
Table Major Players of Stent
Figure Product Picture of PTA Balloon
Table Major Players of PTA Balloon
Table Global Consumption Sales by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2013-2018) ($ million)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Type (2013-2018) ($ Millions)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Type (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Type (2013-2018)
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Hospital
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Hospital (2013-2018) (K Units)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Clinic
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Clinic (2013-2018) (K Units)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Consumed in Other
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Other (2013-2018) (K Units)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Application (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Application (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Application (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Application (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Players (2016-2018) (K Units)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players (2016-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players in 2016
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Players in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players (2016-2018) ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players (2016-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players in 2016
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Players in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Players (2016-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sale Price by Players in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution and Sales Area by Players
Table Players ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
Table ICAD (Intracranial Atherosclerotic Disease) Pathology Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Regions 2013-2018 (K Units)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Regions 2013-2018
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Regions 2013-2018
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Regions 2013-2018 ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Regions 2013-2018
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Regions 2013-2018
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2013-2018 (K Units)
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2013-2018 ($ Millions)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2013-2018 (K Units)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2013-2018 ($ Millions)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2013-2018 (K Units)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2013-2018 ($ Millions)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2013-2018 (K Units)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2013-2018 ($ Millions)
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018) (K Units)
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries (2013-2018)
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries in 2017
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018) ($ Millions)
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries (2013-2018)
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries in 2017
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type (2013-2018) (K Units)
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type in 2017
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application (2013-2018) (K Units)
Table Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application in 2017
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018) (K Units)
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries (2013-2018)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries in 2017
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018) ($ Millions)
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries (2013-2018)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries in 2017
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type (2013-2018) (K Units)
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type in 2017
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application (2013-2018) (K Units)
Table APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application in 2017
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018) (K Units)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries in 2017
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018) ($ Millions)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries in 2017
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type (2013-2018) (K Units)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type in 2017
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application (2013-2018) (K Units)
Table Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application in 2017
Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Spain ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Spain ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Countries in 2017
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries (2013-2018)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share by Countries in 2017
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Type in 2017
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share by Application in 2017
Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Figure GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth 2013-2018 (K Units)
Figure GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth 2013-2018 ($ Millions)
Table ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
Table ICAD (Intracranial Atherosclerotic Disease) Pathology Customer List
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast by Countries (2018-2023) (K Units)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Forecast by Regions
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Forecast by Countries (2018-2023) ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share Forecast by Regions
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Spain ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Spain ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Figure GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption 2018-2023 (K Units)
Figure GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Value 2018-2023 ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast by Type (2018-2023) (K Units)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share Forecast by Type (2018-2023)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Forecast by Type (2018-2023) ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share Forecast by Type (2018-2023)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Forecast by Application (2018-2023) (K Units)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Market Share Forecast by Application (2018-2023)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Forecast by Application (2018-2023) ($ Millions)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Value Market Share Forecast by Application (2018-2023)
Table Stryker Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2016-2018)
Table Balt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2016-2018)
Table TERUMO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
Figure TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2016-2018)
Table MicroPort Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
Figure MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2016-2018)
Table Acandis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share (2016-2018)